Surface modification of continuously extruded contrast-carrying liposomes: Effect on their physical properties

被引:24
作者
Schneider, T
Sachse, A
Leike, J
Rossling, G
Schmidtgen, M
Drechsler, M
Brandl, M
机构
[1] SCHERING AG,ABT PHZE PARENTERALE ARZNEIFORMEN,D-13342 BERLIN,GERMANY
[2] SCHERING AG,ABT FORSCH RONTGENKONTRASMITTEL,D-13342 BERLIN,GERMANY
[3] UNIV FREIBURG,LS PHARMAZEUT TECHNOL,INST PHARMAZEUT,D-79104 FREIBURG,GERMANY
[4] UNIV FREIBURG,INST BIOPHYS,D-79104 FREIBURG,GERMANY
关键词
liposome; contrast agent; continuous extrusion; surface modification; amphipathic polymer; DSPE-PEG; CHOLHS-PEG;
D O I
10.1016/0378-5173(95)04247-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Surface-modified, contrast-carrying liposomes were generated by incorporation of amphipathic polymers into the membranes of continuously extruded vesicles. Besides the well described distearoylphosphatidylethanolamine monomethoxypolyethyleneglycol (DSPE-PEG), a new substance, cholesterylhemisuccinate monomethoxypolyethyleneglycol (CholHS-PEG) was tested for the first time. Using the water-soluble radiographic contrast agent iopromide as well as the nuclear magnetic contrast agent Gd-DTPA, the impact of surface modification (SM) on liposome properties like Vesicle size distribution, encapsulation efficiency, zeta potential and storage as well as plasma stability was investigated. In the course of the studies, the molar amount of amphipathic polymer employed as well as the time point of SM during the production process were varied. Incorporation of both, DSPE-PEG and CholHS-PEG into the lipid films formed before continuous extrusion resulted in a concentration-dependent decline of encapsulation efficiencies. When SM was carried out after vesicle formation, the observed effect diminished and even disappeared, as soon as PEG-coating was carried out after the last extrusion step. However, when using the latter procedure with DSPE-PEC, mean vesicle diameters showed a strong increase in the course of the pegylation process. The extent of bilayer modification was studied by zeta potential measurements of liposomes containing the negatively charged phospholipid SPG. In the presence of PEG-derivatives the high zeta potentials of unmodified vesicles were significantly reduced, irrespective of whether SM was carried out before, during or after extrusion. This result indicated a successful association of the PEG-derivatives with liposomal bilayers for all procedures. For CholHS-PEG complete incorporation into liposomes after extrusion could be demonstrated using gel filtration. Stability testing revealed an unchanged macroscopic appearance, encapsulation efficiency and vesicle size distribution of unmodified and CholHS-bearing liposomes after 4 months' storage at 2-8 degrees C. In contrast to this, DSBE-PEG-containing vesicles displayed a pronounced size increase when SM was carried out during extrusion. Another important effect of DSPE-PEG incorporation was found during plasma stability experiments. Whereas CholHS-PEG-carrying and unmodified liposomes had similar leakage rates in human plasma, DSPE-PEG caused a concentration-dependent decrease in plasma stability, but only when SM had been carried out before extrusion. Altogether, from a merely technological point of view, CholHS-PEG revealed superior properties over DSPE-PEG for SM of continuously extruded contrast-carrying liposomes.
引用
收藏
页码:9 / 21
页数:13
相关论文
共 27 条
[1]  
Allen T.M., 1988, LIPOSOMES DRUG CARRI, P37
[2]  
Allen T.M., 2008, J LIPOSOME RES, V2, P289, DOI [10.3109/08982109209010210, DOI 10.3109/08982109209010210]
[3]   THE USE OF GLYCOLIPIDS AND HYDROPHILIC POLYMERS IN AVOIDING RAPID UPTAKE OF LIPOSOMES BY THE MONONUCLEAR PHAGOCYTE SYSTEM [J].
ALLEN, TM .
ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (03) :285-309
[4]   LARGE UNILAMELLAR LIPOSOMES WITH LOW UPTAKE INTO THE RETICULOENDOTHELIAL SYSTEM [J].
ALLEN, TM ;
CHONN, A .
FEBS LETTERS, 1987, 223 (01) :42-46
[5]   LIPOSOMES FOR THE SUSTAINED DRUG RELEASE INVIVO [J].
BLUME, G ;
CEVC, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1029 (01) :91-97
[6]  
Chonn A, 1992, J Liposome Res, V2, P397, DOI DOI 10.3109/08982109209010217
[7]  
DELGADO C, 1990, BIOTECHNOL APPL BIOC, V12, P119
[8]   RADIOPAQUE LIPOSOMES - A PROMISING NEW CONTRAST MATERIAL FOR COMPUTED-TOMOGRAPHY OF THE SPLEEN [J].
HAVRON, A ;
SELTZER, SE ;
DAVIS, MA ;
SHULKIN, P .
RADIOLOGY, 1981, 140 (02) :507-511
[9]   RADIO-OPAQUE LIPOSOMES FOR THE IMPROVED VISUALIZATION OF FOCAL LIVER-DISEASE BY COMPUTERIZED-TOMOGRAPHY [J].
HENZE, A ;
FREISE, J ;
MAGERSTEDT, P ;
MAJEWSKI, A .
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS, 1989, 13 (06) :455-462
[10]   GADOLINIUM-LABELED LIPOSOMES - TARGETED MR CONTRAST AGENTS FOR THE LIVER AND SPLEEN [J].
KABALKA, G ;
BUONOCORE, E ;
HUBNER, K ;
MOSS, T ;
NORLEY, N ;
HUANG, L .
RADIOLOGY, 1987, 163 (01) :255-258